These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
641 related articles for article (PubMed ID: 26983443)
1. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report. Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443 [TBL] [Abstract][Full Text] [Related]
2. Review of hereditary leiomyomatosis renal cell carcinoma with focus on clinical and pathobiological aspects of renal tumors. Kuroda N; Ohe C; Kato I; Furuya M; Baba M; Nagashima Y; Nakatani Y; Murakami I; Zhou M; Michal M; He O; Amin MB Pol J Pathol; 2017; 68(4):284-290. PubMed ID: 29517197 [TBL] [Abstract][Full Text] [Related]
3. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700 [TBL] [Abstract][Full Text] [Related]
4. Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report. Garg K; Tickoo SK; Soslow RA; Reuter VE Am J Surg Pathol; 2011 Aug; 35(8):1235-7. PubMed ID: 21753700 [TBL] [Abstract][Full Text] [Related]
5. Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer. Gao F; Gu D; Zhang H; Shi C; Du F; Zheng B; Wu H; Zhao Y BMC Med Genomics; 2024 Aug; 17(1):215. PubMed ID: 39160519 [TBL] [Abstract][Full Text] [Related]
6. Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach. Wyvekens N; Valtcheva N; Mischo A; Helmchen B; Hermanns T; Choschzick M; Hötker AM; Rauch A; Mühleisen B; Akhoundova D; Weber A; Moch H; Rupp NJ Genes Chromosomes Cancer; 2020 Nov; 59(11):611-619. PubMed ID: 32537760 [TBL] [Abstract][Full Text] [Related]
7. Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer. Wheeler KC; Warr DJ; Warsetsky SI; Barmat LI Fertil Steril; 2016 Jan; 105(1):144-8. PubMed ID: 26493120 [TBL] [Abstract][Full Text] [Related]
8. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276 [TBL] [Abstract][Full Text] [Related]
9. Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings. Harrison WJ; Andrici J; Maclean F; Madadi-Ghahan R; Farzin M; Sioson L; Toon CW; Clarkson A; Watson N; Pickett J; Field M; Crook A; Tucker K; Goodwin A; Anderson L; Srinivasan B; Grossmann P; Martinek P; Ondič O; Hes O; Trpkov K; Clifton-Bligh RJ; Dwight T; Gill AJ Am J Surg Pathol; 2016 May; 40(5):599-607. PubMed ID: 26574848 [TBL] [Abstract][Full Text] [Related]
10. Fumarate hydratase as a therapeutic target in renal cancer. Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123 [TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature. Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767 [TBL] [Abstract][Full Text] [Related]
12. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287 [TBL] [Abstract][Full Text] [Related]
13. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Trpkov K; Hes O; Agaimy A; Bonert M; Martinek P; Magi-Galluzzi C; Kristiansen G; Lüders C; Nesi G; Compérat E; Sibony M; Berney DM; Mehra R; Brimo F; Hartmann A; Husain A; Frizzell N; Hills K; Maclean F; Srinivasan B; Gill AJ Am J Surg Pathol; 2016 Jul; 40(7):865-75. PubMed ID: 26900816 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas. Furuya M; Iribe Y; Nagashima Y; Kambe N; Ohe C; Kinoshita H; Sato C; Kishida T; Okubo Y; Numakura K; Nanjo H; Nakaigawa N; Makiyama K; Hasumi H; Iwashita H; Ohta J; Kitamura H; Nakajima T; Yoshida T; Nakagawa M; Tanaka R; Yao M J Clin Pathol; 2020 Dec; 73(12):819-825. PubMed ID: 32376712 [TBL] [Abstract][Full Text] [Related]
15. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Alam NA; Rowan AJ; Wortham NC; Pollard PJ; Mitchell M; Tyrer JP; Barclay E; Calonje E; Manek S; Adams SJ; Bowers PW; Burrows NP; Charles-Holmes R; Cook LJ; Daly BM; Ford GP; Fuller LC; Hadfield-Jones SE; Hardwick N; Highet AS; Keefe M; MacDonald-Hull SP; Potts ED; Crone M; Wilkinson S; Camacho-Martinez F; Jablonska S; Ratnavel R; MacDonald A; Mann RJ; Grice K; Guillet G; Lewis-Jones MS; McGrath H; Seukeran DC; Morrison PJ; Fleming S; Rahman S; Kelsell D; Leigh I; Olpin S; Tomlinson IP Hum Mol Genet; 2003 Jun; 12(11):1241-52. PubMed ID: 12761039 [TBL] [Abstract][Full Text] [Related]
16. Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair. Teh J; Kinnear N; Douglass-Molloy H; Hennessey DB BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28122802 [TBL] [Abstract][Full Text] [Related]
17. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients. Joseph NM; Solomon DA; Frizzell N; Rabban JT; Zaloudek C; Garg K Am J Surg Pathol; 2015 Nov; 39(11):1529-39. PubMed ID: 26457356 [TBL] [Abstract][Full Text] [Related]
18. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience. Rabban JT; Chan E; Mak J; Zaloudek C; Garg K Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757 [TBL] [Abstract][Full Text] [Related]
19. Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer. Crooks DR; Cawthon GM; Fitzsimmons CM; Perez M; Ricketts CJ; Vocke CD; Yang Y; Middelton L; Nielsen D; Schmidt LS; Tandon M; Merino MJ; Ball MW; Meier JL; Batista PJ; Linehan WM Hum Mol Genet; 2023 Nov; 32(22):3135-3145. PubMed ID: 37561409 [TBL] [Abstract][Full Text] [Related]
20. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals. Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]